Quickly
Socially
Trending
Crypto
ADAR POONAWALLA
Adar Poonawalla Says Government Should Protect Vaccine Manufacturers From Lawsuits in Case of Adverse Reactions
Oxford COVID-19 Vaccine: SII Responds To Chennai Man's Rs 5 Crore Compensation Notice, Says No Relation Of Medical Condition With Vaccine Trial
Adar Poonawalla Praises Narendra Modi, Says ‘Amazed at How Much Prime Minister Knew About Vaccine’
Covishield Vaccine: Emergency Use Authorisation Request in Two Weeks, Govt Likely to Buy 300-400 Million Doses by July, Says Adar Poonawalla
Oxford COVID-19 Vaccine ‘70% Effective’, Serum Institute Chief Adar Poonawalla Says India Could Give Nod By Year-End
Oxford COVID-19 Vaccine Should be Available for Public by April 2021, Maximum Price Rs 1,000: Seram Institute CEO Adar Poonawalla
COVID-19 Vaccine Covishield May Get Emergency Use Authorisation From India in December 2020, Says Report
When Will COVID-19 Vaccine Covishield, Developed by Oxford-AstraZeneca, Be Available? Adar Poonawalla Responds
After Serum Institute Tweet, Union Health Ministry Says ‘It Disagrees With the Mathematics That Rs 80,000 Crore Is Needed to Vaccinate All Indians’
COVID-19 Vaccine: Rahul Gandhi Echoes Adar Poonawalla's Question, Takes Swipe at PM Narendra Modi's 'Mann Ki Baat'
COVID-19 Vaccine: Adar Poonawalla Says Modi Government Will Take Care of All Needs of Every Indian Day After His Question on Financial Resources
COVID-19 Vaccine Update: Will Modi Govt Have 'Rs 80,000 Crore in Next One Year' to Buy and Distribute Doses? Adar Poonawalla Asks
COVID-19 Vaccine For Everyone Not Possible Before 2024, Says Serum Institute of India Chief Adar Poonawalla
COVID-19 Vaccine Update: Covishield in Trial Phase, Adar and Natasha Poonawalla Meet Oxford University Professor Adrian Hill, Say ‘Super Excited for Next Few Months’
COVID-Vaccine Trials in India: Adar Poonawalla, CEO of Serum Institute of India, Urges Media to Refrain From Reporting on Interim Data About Patients on SII-Covishield Clinical Trials
Google Trends
Live Bot